Rubidium-82 Positron Emission Tomography With Intravenous Ergonovine to Diagnose Vasospastic Angina.
Aged
Coronary Angiography
Coronary Vasospasm
/ diagnosis
Coronary Vessels
/ diagnostic imaging
Ergonovine
/ administration & dosage
Humans
Injections, Intravenous
Male
Oxytocics
/ administration & dosage
Positron-Emission Tomography
/ methods
Radiopharmaceuticals
/ pharmacology
Rubidium Radioisotopes
/ pharmacology
Technetium Tc 99m Sestamibi
/ pharmacology
Journal
The Canadian journal of cardiology
ISSN: 1916-7075
Titre abrégé: Can J Cardiol
Pays: England
ID NLM: 8510280
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
received:
05
01
2021
revised:
25
03
2021
accepted:
26
03
2021
pubmed:
4
4
2021
medline:
28
12
2021
entrez:
3
4
2021
Statut:
ppublish
Résumé
The gold standard to diagnose vasospastic angina is intracoronary reactivity testing, which is performed selectively at dedicated centres. Noninvasive imaging with single-photon emission computerized tomography (SPECT) or echocardiography does not enable accurate localization of spasm or quantification of change in myocardial perfusion in response to an abnormal vasoreactivity. Rubidium-82 positron emission tomography myocardial perfusion imaging (
Identifiants
pubmed: 33812038
pii: S0828-282X(21)00172-0
doi: 10.1016/j.cjca.2021.03.020
pii:
doi:
Substances chimiques
Oxytocics
0
Radiopharmaceuticals
0
Rubidium Radioisotopes
0
Technetium Tc 99m Sestamibi
971Z4W1S09
Rubidium-82
9K730EL8KU
Ergonovine
WH41D8433D
Types de publication
Case Reports
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1661-1664Informations de copyright
Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.